tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Advertisement

Inhibikase Therapeutics (IKT) Similar Stocks

Compare
166 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.66
$120.72M
27.69%
1 Buy
0 Hold
0 Sell
Moderate Buy
Atossa Therapeutics
$1.11
$130.46M
-15.11%
4 Buy
0 Hold
0 Sell
Strong Buy
Anixa Biosciences
$4.92
$146.15M
63.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Spero Therapeutics
$2.36
$128.31M
10.83
90.32%
0 Buy
2 Hold
0 Sell
Hold
Surrozen
$13.75
$120.33M
22.33%
2 Buy
0 Hold
0 Sell
Moderate Buy
TScan Therapeutics
$1.98
$111.79M
-59.44%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.66
0.36
27.69%
ATOS
Atossa Therapeutics
1.18
-0.21
-15.11%
ANIX
Anixa Biosciences
4.92
1.91
63.46%
SPRO
Spero Therapeutics
2.36
1.12
90.32%
SRZN
Surrozen
13.75
2.51
22.33%
TCRX
TScan Therapeutics
2.17
-3.18
-59.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis